GWAS findings are now emerging for psychiatric disorders (Table 5). The early findings include replicated CNV associations for schizophrenia and for autism, a genomewide significant association for bipolar disorder that emerged when several datasets were combined, and a significant association in a combined schizophrenia-bipolar dataset.
